GLP1
-
The $1,500-a-Year GLP-1 Drug Threat to Retirement Savings
Half of GLP-1 users face choosing medication over retirement savings as out-of-pocket costs top $1,500 annually.
-
Weight-Loss Drugs Linked to Less Drinking in Study of 14,000 WeightWatchers Members
WASHINGTON, October 15 — A national survey published in JAMA Psychiatry reveals that nearly half of adults using GLP-1 receptor agonists like…
-
Diabetes Drugs Show Promise in Treating Addiction and Cravings
A class of medications originally developed for diabetes is now being investigated for a completely different purpose: treating addiction. GLP-1 receptor agonists,…
Most read
-
Martin Lewis Warns Savers With £10,000 or More They Could Owe Tax on Interest
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Axos Offers 5.00% Savings Rate for Six Months After Fed Hike, With Strings Attached
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
FDA Approves First Antisense Drug Offering Finite Hepatitis B Therapy
-
Study Finds Autistic Adults Over 45 Face Nearly Triple Parkinsonism Rates
-
Why Former Firefighters Face Lingering Psychological Trauma After Leaving the Career
-
Overcoming Immunotherapy Resistance Takes Center Stage at SITC 2026
-
How Amivantamab’s Dual EGFR-MET Blockade Overcomes Resistance in Head and Neck Cancer
-
The $1,500-a-Year GLP-1 Drug Threat to Retirement Savings
-
Lenacapavir PrEP Costs $42,250 a Year in the U.S. Versus $60 for Generic Pills
-
Star Health’s ₹780 Crore Cancer Payouts Signal Rising Claims Burden for Policyholders
-
How Missing Bank Statements Trigger Medicaid Denials and $41,000 Bills for Nursing Home Residents
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992